A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
A phase 1/2 trial of CAPOX, Capecitabine, Paclitaxel / nab-paclitaxel in metastatic cancer, run by Transcenta Therapeutics (Hangzhou) Co., Ltd., now recruiting.
Overview
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors is a phase 1/2 interventional study registered as NCT04495296 by Transcenta Therapeutics (Hangzhou) Co., Ltd., with 320 participants planned, started 2020-08-13 and due to reach its primary completion in 2026-06-25. Interventions recorded: TST001, Oxaliplatin, Capecitabine, Paclitaxel, Gemcitabine. Conditions listed: Advanced Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Shares TST001, Gemcitabine, Metastatic cancer (cancer that has spread).
- TrialGivastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Shares CAPOX (capecitabine, oxaliplatin), Capecitabine, Nivolumab, Metastatic cancer (cancer that has spread).
- TrialSHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial
Shares Capecitabine, Gemcitabine, Paclitaxel / nab-paclitaxel, Metastatic cancer (cancer that has spread).
- TrialA LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
Shares Capecitabine, Gemcitabine, Nivolumab, Metastatic cancer (cancer that has spread).
- TrialStudy of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
Shares Gemcitabine, Paclitaxel / nab-paclitaxel, Metastatic cancer (cancer that has spread).
- TrialA Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
Shares Capecitabine, Cisplatin, Metastatic cancer (cancer that has spread).
- TrialSpevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junct
Shares CAPOX (capecitabine, oxaliplatin), Gemcitabine, Paclitaxel / nab-paclitaxel.
- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Shares Gemcitabine, Cisplatin, Metastatic cancer (cancer that has spread).